Sensei Biotherapeutics, Inc. (operating as Faeth Therapeutics, Inc.) reported its financial results for the quarter ended September 30, 2026. The company reported cash, cash equivalents and marketable securities of $174.8 million as of September 30, 2026, compared to $21.2 millio